Hyperion DeFi, Inc. (HYPD) Insider Trading Activity

NASDAQ$2.66
Market Cap
$13.27M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
181 of 870
Rank in Industry
26 of 112

HYPD Insider Trading Activity

HYPD Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$641,038
8
100
Sells
$0
0
0

Related Transactions

Strahlman Ellen Rdirector
3
$233,755
0
$0
$233,755
Walters Happy Daviddirector
1
$187,152
0
$0
$187,152
Knox David R.Chief Financial Officer
1
$100,341
0
$0
$100,341
GELTZEILER MICHAEL Sdirector
1
$90,210
0
$0
$90,210
Jung HyunsuSee Remarks
2
$29,580
0
$0
$29,580

About Hyperion DeFi, Inc.

Operating from the United States, Hyperion DeFi, Inc. is a company undergoing a significant shift from its foundational work in ophthalmic drug-delivery, known as Optejet. Its current trajectory involves establishing itself as the inaugural U.S. firm on Nasdaq to hold a cryptocurrency treasury, predominantly denominated in HYPE tokens originating from the Hyperliquid blockchain. Furthermore, Hyperion DeFi oversees the "Kinetiq × Hyperion" validator, persists with its decentralized finance (DeFi) staking strategies, and continues to advance its Optejet UFD™ technology for ocular health.

Insider Activity of Hyperion DeFi, Inc.

Over the last 12 months, insiders at Hyperion DeFi, Inc. have bought $641,038 and sold $0 worth of Hyperion DeFi, Inc. stock.

On average, over the past 5 years, insiders at Hyperion DeFi, Inc. have bought $641,038 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Strahlman Ellen R (director) — $233,755. Walters Happy David (director) — $187,152. Knox David R. (Chief Financial Officer) — $100,341.

The last purchase of 1,000 shares for transaction amount of $3,660 was made by Jung Hyunsu (See Remarks) on 2026‑06‑02.

List of Insider Buy and Sell Transactions, Hyperion DeFi, Inc.

2026-06-02PurchaseJung HyunsuSee Remarks
1,000
0.019%
$3.66
$3,660
-20.27%
2026-06-01PurchaseJung HyunsuSee Remarks
7,000
0.1346%
$3.70
$25,920
-22.24%
2025-12-31PurchaseKnox David R.Chief Financial Officer
27,950
0.4712%
$3.59
$100,341
-0.66%
2025-12-29PurchaseStrahlman Ellen Rdirector
23,968
0.4058%
$3.60
$86,403
+1.04%
2025-12-26PurchaseStrahlman Ellen Rdirector
6,912
0.1253%
$3.86
$26,688
-7.99%
2025-12-18PurchaseStrahlman Ellen Rdirector
38,444
0.5667%
$3.14
$120,664
+18.33%
2025-12-17PurchaseWalters Happy Daviddirector
61,930
0.8789%
$3.02
$187,152
+20.75%
2025-12-17PurchaseGELTZEILER MICHAEL Sdirector
30,000
0.4237%
$3.01
$90,210
+20.75%
Total: 8
*Gray background shows transactions not older than one year

HYPD Institutional Investors: Active Positions

Increased Positions18+72%1M+211.47%
Decreased Positions8-32%106,961-22.25%
New Positions13New788,379New
Sold Out Positions3Sold Out20,600Sold Out
Total Postitions35+40%1M+189.21%

HYPD Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

No data is available at this moment.

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.